Announcements Trials
Browse Landscape

Phase

Phase NA 3Phase EARLY_PHASE1 1Phase 2 1

Status

Completed 4Active not recruiting 1

Sponsor Class

OTHER 5FED 1

Study Type

Interventional 5

Sponsor

Cancer Type

Breast 2Dermatologic 1

Conditions

Breast Neoplasms 1152Prostatic Neoplasms 642Neoplasms 581Carcinoma, Non-Small-Cell Lung 488Multiple Myeloma 483Leukemia, Myeloid, Acute 461Leukemia 418Lung Neoplasms 399Lymphoma 381Leukemia, Lymphocytic, Chronic, B-Cell 332Precursor Cell Lymphoblastic Leukemia-Lymphoma 327Lymphoma, Non-Hodgkin 326Colorectal Neoplasms 310Pancreatic Neoplasms 306Neoplasm Metastasis 302Myelodysplastic Syndromes 301Melanoma 286Hodgkin Disease 253Head and Neck Neoplasms 249Brain Neoplasms 231Lymphoma, Follicular 224Ovarian Neoplasms 221Recurrence 220Glioblastoma 215Lymphoma, Mantle-Cell 211Lymphoma, Large B-Cell, Diffuse 209Squamous Cell Carcinoma of Head and Neck 176Colonic Neoplasms 162Carcinoma, Renal Cell 158Carcinoma, Hepatocellular 154

Interventions

beta-Aminoethyl Isothiourea 1Trastuzumab 1Patient Navigation 1N-(3-chloro-4-((3-fluorobenzyl)oxy)phenyl-6-(5-((methylsulfonyl)ethyl)aminomethyl)-2-furyl)-4-quinazolinamine 1Lapatinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
OTHER × Has results × Patient Compliance × Clear all
NCT05465408 2026-02-24

Culturally Aware AET Non-Initiation Intervention

Massachusetts General Hospital

Phase NA Completed
35 enrolled 7 charts
Breast

Treatment Adherence and Compliance, Breast Neoplasms, Patient Compliance, Treatment Refusal

NCT01273610 2025-06-10

Tolerability of the Combination of Lapatinib and Trastuzumab in Adults Age 60 or Older With HER2 Positive Locally Advanced or Metastatic Breast Cancer

City of Hope Medical Center

Phase 2 Active not recruiting
40 enrolled 15 charts
Breast

Breast Neoplasms, Patient Compliance

NCT03478397 2024-04-19

ATICA

Centro de Estudio de Estado y Sociedad

Phase NA Completed
5,389 enrolled 6 charts

Patient Compliance

NCT02553538 2018-03-26

Improving Comprehensive Cancer Screening Among Vulnerable Patients Using Patient Navigation

Massachusetts General Hospital

Phase NA Completed
1,612 enrolled 13 charts

Patient Compliance

NCT00535769 2012-07-20

Evaluation of Adherence to Topical Agents: Applying Communication Technology to Improve Sunscreen Use

Massachusetts General Hospital

Phase EARLY_PHASE1 Completed
70 enrolled 7 charts
Dermatologic

Patient Compliance, Skin Neoplasms, Medication Adherence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡